Gamma camera probe developer Neoprobe has established a European business unit to address European Union development and commercialization needs for its technologies, including its Lymphoseek radiopharmaceutical.
The new European business unit is part of Neoprobe's expanding focus on global sales opportunities, according to the vendor. The company said it plans to establish relationships with European partners that can provide marketing, sales, and distribution services.
